Company > Strategy
Lan Chem Laboratories aims to become a leading hospital pharmaceuticals business selling products directly to anesthesiologists and oncologists in the UK. The key elements of this strategy are:
-
Directly commercialize Barhemsys® and Byfavo® in the UK through our own sales and marketing infrastructure.
-
Establish strategic partnerships for the commercialization of Barhemsys® and APD403 outside the UK with companies that have local expertise and commercial infrastructure, initially focusing on the major pharmaceutical markets.
-
Leverage our UK commercial infrastructure to sell APD403 for CINV to oncologists.
-
Consider the further in-licensing or acquisition of complementary products or product candidates that can be commercialized effectively through our UK organization.
